CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53
- PMID: 19805293
- PMCID: PMC2752525
- DOI: 10.1073/pnas.0904305106
CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53
Erratum in
- Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18427. Kung, Andrew [corrected to Kung, Andrew L]
Abstract
p300 and CREB-binding protein (CBP) act as multifunctional regulators of p53 via acetylase and polyubiquitin ligase (E4) activities. Prior work in vitro has shown that the N-terminal 595 aa of p300 encode both generic ubiquitin ligase (E3) and p53-directed E4 functions. Analysis of p300 or CBP-deficient cells revealed that both coactivators were required for endogenous p53 polyubiquitination and the normally rapid turnover of p53 in unstressed cells. Unexpectedly, p300/CBP ubiquitin ligase activities were absent in nuclear extracts and exclusively cytoplasmic. Consistent with the cytoplasmic localization of its E3/E4 activity, CBP deficiency specifically stabilized cytoplasmic, but not nuclear p53. The N-terminal 616 aa of CBP, which includes the conserved Zn(2+)-binding C/H1-TAZ1 domain, was the minimal domain sufficient to destabilize p53 in vivo, and it included within an intrinsic E3 autoubiquitination activity and, in a two-step E4 assay, exhibited robust E4 activity for p53. Cytoplasmic compartmentalization of p300/CBP's ubiquitination function reconciles seemingly opposed functions and explains how a futile cycle is avoided-cytoplasmic p300/CBP E4 activities ubiquitinate and destabilize p53, while physically separate nuclear p300/CBP activities, such as p53 acetylation, activate p53.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2752525/bin/zpq9990995480001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2752525/bin/zpq9990995480002.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2752525/bin/zpq9990995480003.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2752525/bin/zpq9990995480004.gif)
Similar articles
-
Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation.Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19290-5. doi: 10.1073/pnas.1013078107. Epub 2010 Oct 20. Proc Natl Acad Sci U S A. 2010. PMID: 20962272 Free PMC article.
-
A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity.Cell Death Dis. 2015 Feb 12;6(2):e1634. doi: 10.1038/cddis.2015.17. Cell Death Dis. 2015. PMID: 25675294 Free PMC article.
-
The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression.Nature. 2005 Dec 1;438(7068):690-5. doi: 10.1038/nature04151. Nature. 2005. PMID: 16319895
-
Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.J Biol Chem. 2016 Mar 25;291(13):6714-22. doi: 10.1074/jbc.R115.692020. Epub 2016 Feb 5. J Biol Chem. 2016. PMID: 26851278 Free PMC article. Review.
-
Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformation.Br J Cancer. 2006 Sep 4;95(5):555-60. doi: 10.1038/sj.bjc.6603304. Epub 2006 Aug 1. Br J Cancer. 2006. PMID: 16880778 Free PMC article. Review.
Cited by
-
Proximity labelling of pro-interleukin-1α reveals evolutionary conserved nuclear interactions.Nat Commun. 2024 Aug 8;15(1):6750. doi: 10.1038/s41467-024-50901-0. Nat Commun. 2024. PMID: 39117622 Free PMC article.
-
Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer.Exp Mol Med. 2023 Oct;55(10):2220-2237. doi: 10.1038/s12276-023-01091-0. Epub 2023 Oct 2. Exp Mol Med. 2023. PMID: 37779142 Free PMC article.
-
EP300 promotes ferroptosis via HSPA5 acetylation in pancreatic cancer.Sci Rep. 2023 Sep 11;13(1):15004. doi: 10.1038/s41598-023-42136-8. Sci Rep. 2023. PMID: 37696842 Free PMC article.
-
EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs.Int J Mol Sci. 2023 Aug 1;24(15):12302. doi: 10.3390/ijms241512302. Int J Mol Sci. 2023. PMID: 37569677 Free PMC article. Review.
-
Mechanistic insights into the dual role of CCAR2/DBC1 in cancer.Exp Mol Med. 2023 Aug;55(8):1691-1701. doi: 10.1038/s12276-023-01058-1. Epub 2023 Aug 1. Exp Mol Med. 2023. PMID: 37524873 Free PMC article. Review.
References
-
- Michael D, Oren M. The p53 and Mdm2 families in cancer. Curr Opin Genet Dev. 2002;12:53–59. - PubMed
-
- Moll UM, Wolff S, Speidel D, Deppert W. Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol. 2005;17:631–636. - PubMed
-
- Slee EA, O'Connor DJ, Lu X. To die or not to die: How does p53 decide? Oncogene. 2004;23:2809–2818. - PubMed
-
- Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer. 2004;4:793–805. - PubMed
-
- Morgunkova A, Barlev NA. Lysine methylation goes global. Cell Cycle. 2006;5:1308–1312. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous